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1. Introduction
   In contrast to its role as poison, hydrogen sulfide (H2S) 
is now considered as 3rd gas transmitter after nitric oxide 
and carbon monoxide[1,2]. Though H2S was first reported 
to be produced in mammalian tissues in 1982, it is only 
now emerging as a mediator of important physiologic 
functions[3]. H2S is endogenously produced from the amino 
acid L-cysteine, by two key enzymes that are involved in the 
trans-sulphuration pathway, cystathionine-b-synthetase 
and cystathionine γ-lyase. These two enzymes are 
distributed in a wide range of tissues, including the pancreas, 
and their expression and activities have been shown to be 
altered in a variety of pathophysiological conditions[1,4-6]. A 
third H2S synthesizing enzyme, 3-mercapto suifer transferase 
also exits. 3-mercaptosuifer transferase generates H2S from 
3-ercaptosuifertransferese which produced from L-cystine 
by cysteine aminotransferase[7].
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Objective: To evaluate the plasma H2S levels and H2S synthesis activity in streptozotocin induced 
type 2 diabetes rats compared to the healthy controls and also to observe the effect of the aqueous 
extract of Swietenia macrophylla (S. macrophylla) seeds on the experimental groups.
Methods: Seeds of S. macrophylla were separated, washed, shed-dried and finally extract was 
prepared. Thirty two wistar rats were selected for the experimental study. Streptozotocin was used 
for the induction of diabetes. H2S concentration in plasma was measured. H2S synthesizing activity 
in plasma was measured. Statistical analysis have done using Microsoft excel, Office 2003. Values 
were expressed by mean依SD. P<0.05 were considered statistically significant.
Results: Fasting blood glucose level (7.74依0.02) mmol/L was significantly increased in diabetic 
rats. The glucose levels are significantly lowered in the rats treated with metformin (5.48依0.03) 
mmol/L as well as with aqueous extract of S. macrophylla seeds (3.72依0.04) mmol/L. The HbA1c 
percentages in different groups of study subjects also indicate similar trends. Our study shows 
both the plasma H2S levels (22.07依0.73) mmol/L and plasma H2S synthesis activity (0.411依0.005 
mmol/100 g) are significantly reduced in the streptozotocin induced diabetic rats. 
Conclusions: Although considering a small sample size, it can conclude that the fasting blood 
glucose levels are inversely related to plasma H2S levels as well as H2S synthesis activity in 
plasma and the extract of S. macrophylla is associated with increased plasma H2S levels with 
effective lowering of blood glucose in streptozotocin induced diabetic rats.
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   H2S regulates several cellular and physiological phenomena 
such as vasorelaxation, hormone secretion, inflammatory 
responses and apoptosis[5,7-11]. In the central nervous system, 
H2S functions not only as a neuro-modulator, but also as a 
neuro-protectant against oxidative stress[12].
   Recent reports suggest that H2S play an important role 
in pathophysiology of many diseases including diabetes 
mellitus, Alzheimer’s disease, hypertension, and cardiac 
infarction[4,8,12,13]. Recent studies revealed the important 
role of H2S in regulation insulin release from the β cells of 
pancreas. The insulin secretion depends upon K+ ATP channel 
opening and closing in the β cells. The main factor controlling 
the secretion of insulin is the blood glucose concentration. 
ATP-sensitive K+-channel determines the resting membrane 
potential in β cells via a membrane transporter called GLUT-2 
and its subsequent metabolism via glycolysis increases 
intracellular ATP. This blocks K+ATP causing membrane 
depolarization and opening of voltage dependant calcium 
channels, leading to Ca+ signal which induces insulin 
secretion. The insulin secretion is depending upon K+ATP 
channel opening and closing. H2S inhibits the closing of 
K+ATP and release of insulin. Thereby it prevents exhaustion 
of β cells and regulates β cell survival. H2S is K
+ATP channel 
opener and it has no effect on ATP concentration, may be 
acting by direct interaction with protein[14,15].
   A report suggested pancreatic synthesis of H2S is markedly 
elevated in streptozotocin induced rats which have biphasic 
effect on β-cells. At low concentrations H2S shown to inhibit 
insulin release through K+ATP dependent Ca2+ independent 
mechanism, whereas higher levels induced β-cell death 
through endoplasmic-reticular-stress-dependent 
pathways[16].
   In addition, the changes in H2S haemostatics also play 
a role in the pathogenesis of endothelial injury which 
developed under the basis of elevated circulation of blood 
glucose level in diabetes[16].
   Previous studies demonstrated the induction of H2S-
producing enzymes in animals treated with the β-cell toxin 
streptozotocin[17]. The H2S-producing activity increases in 
the liver and pancreas of streptozotocin treated diabetic rats 
whereas the plasma H2S levels are unchanged[17]. Increases 
in cystathionine-b-synthetase and cystathionine γ-lyase 
expression and H2S production in these diabetic tissues are 
reversed by insulin treatment, suggesting that this may be 
a secondary result from hyperglycemia or hypoinsulinemia. 
However, other studies in this direction have given 
contradictory findings[17].
   The modulation of H2S production may be a potential 
therapeutic strategy for these diseases. This possibility led 
the researchers to investigate H2S-related substances for 
treatment of diabetes[9,16]. The cytoprotective effects of H2S 
are particularly interesting because exhaustion of β-cells is 
an important process in the pathogenesis of type 2 diabetes 
mellitus, and the prevention of β-cell exhaustion may be a 
new strategy for the treatment of this disease.
   Earlier we have reported that Swietenia macrophylla 
(S. macrophylla) which is a natural occurring plant are 
quite effective in controlling the blood glucose levels and 
the aqueous extract of the seeds have also antioxidant 
property[18]. We also observed that its helps to regenerate the 
β-cells in streptozotocin induced diabetic rats[18].
   The present investigation was undertaken to evaluate the 
plasma H2S levels and H2S synthesis activity in streptozotocin 
induced type 2 diabetes rats compared to the healthy controls 
and also to observe the effect of the aqueous extract of S. 
macrophylla seeds on the above experimental groups.
2. Materials and methods
2.1. Plant material
   Seeds of S. macrophylla were collected from Botanical 
Survey of India, Ministry of Environment and Forest, 
Government Of India, Howrah, 711103 on 4th February, 2010, 
authenticated by the Botanical Survey of India. A voucher 
specimen (Ref. no. CNH/I-I/54/2009/Tech.II/154) was deposited 
at our laboratory for further reference.
2.2. Preparation of extract
   The seeds of S. macrophylla were separated, washed, shed-
dried at room temperature, powdered and sieved through 40 
meshes 1 mL of distilled water was added to 200 mg powder 
to make the solution. After that the solution was centrifuged 
at 3 000 r/min for 15 min. The supernatant was filtrated and 
collected. The pure extract of S. macrophylla was stored in 
glass vial sealed by air tight lid. 
2.3. Animal models 
   Thirty two wistar rats (180-240 g) were selected for the 
experiment. The animal were kept under standard condition 
of 12:12 h light and dark cycle in a polythene cage and fed 
with standard laboratory diet and water ad libitum. The 
principle of laboratory animals care and the instructions 
given by our institutional ethical committee were followed 
throughout the experiment. Streptozotocin was used for the 
induction of diabetes by the intraperitoneal route except 
in normal healthy controls. Hyperglycaemia was induced 
in overnight fasted adult wistar strain albino rats weighing 
180-240 g by a single intraperitoneal injection of 65 mg/kg 
streptozotocin in a volume of 1 mL/kg body weight[19]. Due to 
the instability of streptozotocin in aqueous media, the solution 
was made in citrate buffer (pH 4.5) just before injection[20]. 
Hyperglycaemia was confirmed by the elevated glucose level 
in plasma, determined at 48 h after injection. The rats found 
hyperglycaemic were further screened for the study.
2.4. Experimental design
   Animal were divided into four groups of eight rats each and 
further experiments carried out using six rats in each group.
   Group I (Normal Control): Normal rats administered with 
double distilled water for 30 d.
   Group II (Diabetic Control): Diabetic control rats, also 
administered with distilled water.
   Group III (Diabetic rats with metformin): Diabetic rats 
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administered aqueous extract of metformin (10 mg/kg body 
weight).
   Group IV (Diabetic rats with extract): Diabetic rats 
administered aqueous extract of S. macrophylla seeds daily 
for 30 d.
2.5. Measurement of H2S concentration in plasma 
   H2S concentration in plasma was measured following the 
method described earlier[11]. Plasma was collected from 
rat blood before sacrifice followed by centrifugation. 75 µL 
plasma was mixed with 250 mL 1% (w/v) zinc acetate and 425 
mL distilled water in a tube. Then 20 mmol/L N-dimethyl-p-
phenylenediamine sulphate in 7.2 mmol/L HCl (133 mL) and 
30 mmol/L FeCl3 in 1.2 mmol/L HCl (133 mL) were also added 
to the test tube for 10 min incubation at room temperature. 
The protein in the plasma was removed by adding 250 mL of 
10% tricholoacetic acid to the reaction mixture and pelleted 
by centrifugation at 3 000 r/min for 15 min. The absorbance 
of the resulting solution at 670 nm was measured with a 
spectrophotometer. All samples were assayed in duplicate 
and concentration in the solution was calculated against a 
calibration curve of NaHS (3.125-250 mmol/L). 
2.6. Measurement of H2S synthesizing activity 
   H2S synthesizing activity in plasma is measured by 
following method of Kun Qu et al. with some modification. 
One hundred µL of plasma is taken in a vial with 0.3 mL of 
1% zinc acetate. Throughly mixed capped with airtight cap 
incubated at 37 °C for 90 min. Half mL of 50% trichloroacetic 
acid injected into the reaction mixture through the cap 
and incubated for another 60 min. Then 50 µL of mmol/
L N, N-dimethyl-p-henylenediamine sulphate in 7.2 mol/
L HCl and 50 µL of 30 mmol/L FeCl3 in 1.2 mol/L HCl were 
added into the tube through the cap. Incubated for further 20 
min at 37 °C and absorbance was measured at 670 nm using 
spectrophotometer. H2S concentration was taken as 30% of the 
NaHS concentration in the calculation. The calibration curve 
was linear from 0 to 320 mmol/L NaHS or 96 mmol/L H2S. 
2.7. Measurement of other biochemical parameters 
   Measurement of blood glucose, urea, creatinine, SGOT, 
SGPT and HbA1c were done using standardised reagent kits 
(Ranbaxy).
2.8. Statistical analysis
   Statistical analysis have done using Microsoft excel, Office 
2003. Values were expressed by mean依SD. P<0.05 were 
considered statistically significant.
3. Results
   The results of different biochemical parameters in the 
current study have been depicted in Table 1. Fasting blood 
glucose level (7.74依0.02) mmol/L was significantly increased 
in diabetic rats (Group II) in comparison to healthy control 
ones (Group I) (4.04依0.02) mmol/L. The glucose levels are 
significantly lowered in the rats treated with metformin 
(5.48依0.03) mmol/L as well as with aqueous extract of S. 
macrophylla seeds (3.72依0.04) mmol/L. In the current study 
the plasma H2S levels in the control group was within the 
range of 23.45 to 26.83 mmol/L (25.00依0.14) mmol/L. 
   The current study observed both the plasma H2S levels (22.07
依0.73) mmol/L and plasma H2S synthesis activity (0.411依0.005) 
mmol/100 g were significantly reduced in the streptozotocin 
induced diabetic rats. Whereas the plasma H2S levels in the 
rats treated with metformin [Group III, (25.97依0.1) mmol/L] and 
the aqueous extract of S. macrophylla (Group IV, 36.85依0.64 
mmol/L) was significantly increased compared with diabetic 
rats. The plasma H2S synthesis activity of healthy control, 
diabetic control, diabetes on metformin and extract were (51.6
依0.08), (41.1依0.05), (47.5依3.0) and (70.2依0.09) mmol/100 g protein 
respectively. Therefore, our study results show both plasma 
H2S level and H2S synthesis activity is significantly enhanced 
with the reduction blood glucose levels (Figures 1-4).  
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Figure 1. Relationship of plasma fasting blood glucose levels (mmol/L) and 
plasma H2S concentration (mmol/L).
Table 1
Biochemical parameters of the study subjects.
Parameters  Normal Control Diabetic Control Diabetic rats with Metformin  Diabetic rats with extract 
Plasma H2S Levels (mmol/L) 25.14依1.69  22.07依0.73  25.97依0.10   36.85依0.64
a
Plasma H2S Synthesis Activity (mmol/100 g of protein) 51.60依0.08  41.10依0.05  47.50依3.00   70.20依0.09
b
Body weight (g) 105.78依4.31 107.30依4.91 108.03依5.49 108.32依4.20
Fasting blood glucose (mmol/L)    4.04依0.02   7.74依0.02   5.48依0.03    3.72依0.01
HbA1c (%)    5.50依0.06   5.80依0.10   5.00依0.06    3.80依0.12
Urea (mg/dL)  22.95依2.43  24.45依3.40  20.05依2.11  19.56依1.40
Creatinine (mg/dL)   0.50依0.09    0.70依0.07   0.67依0.01    0.40依0.02
SGOT ( U/L)  42.22依3.59  46.83依4.79  46.66依9.24  42.66依1.96
SGPT (U/L)  38.91依3.20  42.16依3.86  39.83依3.76   34.16依2.85a
Paired two tail student’s T test was done. Values are expressed as mean依SD. Indicate the level of significance in comparison to the healthy controls (Group I). aP<0.05; bP<0.01.
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Figure 2. Relationship of plasma fasting blood glucose levels (mmol/L) and 
plasma H2S synthesis activity (mmol/100 g of protein).
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Figure 3. Correlation of fasting blood glucose and H2S levels in 
streptozotocin induced diabetic rat.
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Figure 4. Correlation of fasting blood glucose and H2S level synthesis 
activity in streptozotocin induced diabetic rat.
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4. Discussion
   The current study showed fasting blood glucose level 
significantly increased in diabetic rats compared to healthy 
controls along with the glucose levels being significantly 
lowered in the rats treated with metformin as well as with 
aqueous extract of S. macrophylla seeds and this conforms 
with the findings of our previously reported study[18]. Even 
the glycated haemoglobin percentages in different groups 
of study subjects also had similar trends of our previously 
reported study[18].
   In the current study the plasma H2S levels in the control 
group is within the range and it is in good agreement with 
study conducted elsewhere[7]. However, all studies didn’t 
conform to the findings of the current study and had reported 
some contradictory findings. One of the study reported that 
the streptozotocin induced diabetes in the rat is associated 
with enhanced tissue hydrogen sulphide biosynthesis[17]. 
Another study suggested that H2S synthesis is progressively 
reduced as diabetic pathology increased[21].
   The current study shows that both plasma H2S levels and 
plasma H2S synthesis activity are significantly reduced in 
the streptozotocin induced diabetic rats. Whereas the plasma 
H2S levels in the rats treated with metformin and the aqueous 
extract of S. macrophylla is significantly increased compared 
to diabetic rats. The extract treated rats having lowest blood 
glucose levels, show highest levels of H2S and H2S synthesis 
activity in plasma. Plasma H2S synthesis activity also shows 
similar observations. Therefore, our study results show both 
plasma H2S level and H2S synthesis activity is significantly 
enhanced with the reduction blood glucose levels. Earlier 
study described that the blood glucose level is significantly 
higher and insulin level significantly lower in animal treated 
with NaHS and H2S donar compared to the control group. 
According to JIA, H2S concentration reported to be higher in 
Juker diabetic rats compare to the juker lean rats. According to 
their study H2S increases glucose level and decreases insulin 
levels[22]. In our study both H2S levels and H2S synthesis 
activity is increased with decrease of plasma glucose levels 
and these are well correlated. H2S levels especially under the 
effect of the extract is associated with further decrease in the 
plasma glucose concentration Previously we have reported 
that the aqueous extract have significantly antioxidant effect 
and also helps to regenerate the β-cells. Increased plasma 
H2S level may also contribute for regeneration of the β-cells 
observed in our earlier study. The higher H2S levels observed 
in our study may be due to other factors involved in the H2S 
bioavailability in the vasculature. 
   Although considering a small sample size, we conclude 
that the fasting blood glucose levels are inversely related 
to plasma H2S levels as well as H2S synthesis activity in 
plasma and the extract of S. macrophylla is associated with 
increased plasma H2S levels with effective lowering of blood 
glucose in streptozotocin induced diabetic rats.
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highlights the link of H2S and diabetes. Also the role of 
herbal plant product swietenia macrophylla is being studied 
as a protector of damage in pancreatic tissue leading to 
progression of diabetes. 
  
Research frontiers
   The relationship of H2S with pancreatic tissue efficiency 
in production and synthesis of insulin is being the current 
trend and the importance and cutting edge finding of this 
research study. Also the relationship of S. macrophylla with 
H2S is established which is not reported earlier. 
Related reports
   Earlier studies have been done but no concrete findings 
have been reported and there was not extreme analysis 
on diabetes with H2S as reported in the current study. The 
materials and methods are good and it is done in a research 
based university. The finding/s of this study would be of 
immense importance for re-thinking the role of H2S in 
diabetes.
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   The current study is innovative and gives us an idea to 
explore further and to re-think why and how H2S affects 
pancreatic tissue and its role in insulin release and its 
importance in diabetes and hypoglycemic states.
  
Applications
   Point of care management of diabetes with application 
of H2S being used as a marker of its disorder and linking 
with herbal product is of significance as it does not have 
any side-effects and contraindications compared to the 
traditional ones.    
Peer review
   Over all the paper is very informative and gives very 
scientific information, which makes us to rethink about the 
relationship of H2S and diabetes mellitus.
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